Athira Pharma, Inc. Rings the Closing Bell in Celebration of its IPO

ABOUT THIS EVENT

Athira Pharma, Inc. (Nasdaq: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, rings the Nasdaq Closing Bell remotely from across the country.

In celebration of its IPO, Leen Kawas, PhD, President & CEO, rings the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.